Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while placing his company for growth in a changing regulatory landscape.
PUBLICATION DATE: April 12, 2011 PRODUCT #: 511050-PDF-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
Medical Equipment Inc. in Saudi Arabia
Negotiation Analysis: An Introduction
Alphatech India Limited: B2B Customer Retention
Going Flat: Pursuit of a Democratic Organizational Structure
Ethics Hold the Key to Network Contradictions
Blind Spots: The Roots of Unethical Behaviour in Life and Work
Governance Failure at Satyam
Rein Chemical Co.: Specialty Division
The Ethics of Fundraising (C): The Catchere Gift and the Admissions Director
Martin Marietta: Managing Corporate Ethics (B)
